Skip to main content

RGNT · Regentis Biomaterials Ltd. · Shareholders & Ownership

Track RGNT — free
$1.47 -0.01 (-0.68%)
Market Cap
$10.40M
Shares
7.02M
Volume · Oct 20 13.66K Avg daily vol (3M) 59.01K

Every disclosed holder of RGNT in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns RGNT

13F quarter Jun 30, 2026

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 845,791 —
Insiders (Forms 3, 4, 5) 259,131 —
13D/G-only blocks 1,332,867 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: a foreign private issuer reports ordinary shares, a different unit from the listed shares.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of RGNT

# Holder Shares
1
Dr. Ehud Geller
13G CIK 1284386 · Unknown · Dec 31, 2025
Rule 13d-1(d), exempt investor
1,332,867
2
Rosalind Advisors, Inc.
13F CIK 1622627 · Unknown · Jun 30, 2026
701,685
3
Dykan Jeff
Insider CIK 1661229 · Mar 18, 2026
Director, issuer-wide
130,465
4
Ben-Elazar Pini
Insider CIK 2114839 · Mar 18, 2026
Director, issuer-wide
128,666
5
Warberg Asset Management LLC
13F CIK 1597506 · Unknown · Jun 30, 2026
86,980
6
JANE STREET GROUP, LLC
13F CIK 1595888 · Unknown · Jun 30, 2026
43,333
7
RENAISSANCE TECHNOLOGIES LLC
13F CIK 1037389 · Registered investment adviser · Jun 30, 2026
13,348
8
UBS Group AG
13F CIK 1610520 · Bank · Jun 30, 2026
434
9
Tower Research Capital LLC (TRC)
13F CIK 1533421 · Unknown · Jun 30, 2026
11

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1912966 CUSIP M8211G108 Visit website Investor relations